Thromboembolic Pulmonary Hypertension
📧 Sign up to get email alerts when something new happens for Thromboembolic Pulmonary Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-01-21Clinical Trial Update: Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany
A prospective registry is being conducted to determine the effective incidence of chronic thromboembolic pulmonary hypertension in Germany.
-
CLINICAL_TRIALS research · 2016-01-06Clinical Trial Update: Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Clinical trial update on riociguat for chronic thromboembolic pulmonary hypertension (CTEPH); the trial is no longer available on ClinicalTr…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension. [Phase 3]
Phase 3 trial of ambrisentan for inoperable chronic thromboembolic pulmonary hypertension was terminated. Results were posted in 2015.
-
FDA approval · 2015-12-04FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for ADEMPAS (riociguat) from Bayer HealthCare Pharmaceuticals Inc. This action updates the exist…
-
CLINICAL_TRIALS research · 2015-04-28Clinical Trial Update: 3D Echocardiographic Assessment of RV Function in Patients Undergoing Pulmonary Endarterectomy
This clinical trial update reports on using 3D echocardiography to assess right ventricular function in patients undergoing pulmonary endart…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-02-23FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved Bayer HealthCare Pharmaceuticals Inc.'s supplemental application for ADEMPAS (riociguat).
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients [NA]
Completed clinical trial evaluating lung-protective ventilation in patients undergoing pulmonary thromboendarterectomy for chronic thromboem…
-
FDA approval · 2014-06-11FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) from Bayer HealthCare Pharmaceuticals Inc., approving a supplemental submiss…
-
FDA approval · 2014-05-06FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) submitted by Bayer HealthCare Pharmaceuticals Inc. The action pertains to th…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. [Phase 3]
Phase 3 trial evaluating efficacy and safety of oral BAY63-2521 in patients with chronic thromboembolic pulmonary hypertension (CTEPH) has c…
-
CLINICAL_TRIALS research · 2014-02-27Clinical Trial Update: Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
An epidemiological study in China is evaluating the long-term risk of adverse events after pulmonary embolism, in the context of chronic thr…
-
FDA approval · 2013-10-08FDA Approved: ADEMPAS — Original Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved Adempas (riociguat) from Bayer as the original application for treatment of pulmonary arterial hypertension and chronic thr…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension [NA]
Clinical trial update investigating criteria for successful endarterectomy in chronic thromboembolic pulmonary hypertension; study completed…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Phase 3]
Phase 3 study results update for bosentan in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH).
-
CLINICAL_TRIALS research · 2012-08-24Clinical Trial Update: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incidence in Patients With Central Versus Peripheral Embolism
Clinical trial update on the incidence of chronic thromboembolic pulmonary hypertension in patients with central versus peripheral embolism.…
-
CLINICAL_TRIALS research · 2010-07-15Clinical Trial Update: Right Ventricular Resynchronization Therapy [NA]
An update on clinical trial NCT01163422 shows the study status is unknown. The trial involves right ventricular failure and chronic thromboe…
-
CLINICAL_TRIALS research · 2006-07-06Clinical Trial Update: Gene Mutations in Secondary Pulmonary Hypertension
An update on a Medical University of Vienna clinical trial investigating gene mutations in chronic thromboembolic pulmonary hypertension; th…